Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06936696 · ClinicalTrials.gov registry record · NA

Project PAIR: Parent-implemented Articulation Intervention With Recast

A NA study of Hearing Impaired Children, sponsored by Vanderbilt University.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06936696 is a NA study of Hearing Impaired Children that is actively recruiting participants, run by Vanderbilt University. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06936696, a NA study of Hearing Impaired Children, is actively recruiting participants, sponsored by Vanderbilt University.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Using a single-case multiple baseline across participants design, this study aims to explore the effectiveness of parent-implemented Broad Treatment Speech Recast supplemented with traditional clinician-led articulation therapy on speech production in elementary-aged deaf and hard of hearing children. To address these objectives, the following research questions will be investigated: 1. Does drill-based articulation therapy, administered by a speech-language pathologist, improve speech sound production in DHH children when parent-implemented BTSR is concurrently utilized at home? 2. Does the combination of parent-implemented BTSR and clinician-led traditional articulation therapy result in generalization of speech sound accuracy at the conversation level?

Conditions Studied

Interventions

  • BEHAVIORAL Broad Target Speech Recast
  • BEHAVIORAL Traditional Speech Therapy

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-06-10
Est. Completion 2026-08
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT06936696

The ClinicalTrials.gov registry entry for NCT06936696 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hearing Impaired Children appearing as the primary indexed condition, and to 2 interventions - of which Broad Target Speech Recast is the first listed.

NCT06936696 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT06936696 about?

NCT06936696 is a clinical study titled "Project PAIR: Parent-implemented Articulation Intervention With Recast". Using a single-case multiple baseline across participants design, this study aims to explore the effectiveness of parent-implemented Broad Treatment Speech Recast supplemented with traditional clinician-led articulation therapy on speech production in elementary-aged deaf and hard of hearing childre...

What is the current status of trial NCT06936696?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-06-10. Estimated completion is 2026-08.

What conditions does trial NCT06936696 study?

This clinical trial studies the following conditions: Hearing Impaired Children.

What interventions are being tested in trial NCT06936696?

The interventions under investigation include: Broad Target Speech Recast (BEHAVIORAL), Traditional Speech Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06936696?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06936696 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.